IP Library Patent Application 11360859
Patent Application
App. No. 11/360,859

Methods for mutation detection

Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US None
App. No.
11/360,859
Abstract

The invention relates to methods for detecting a mutation in a nucleic acid. Methods of the invention are useful for detecting and identifying mutations that are indicative of disease or the predisposition for disease.

Claims (53)

1 . A method for detecting a mutation in a target nucleic acid, the method comprising the steps of:

(a) exposing an individually-optically detectable target nucleic acid template suspected to contain a mutation to a primer capable of hybridizing to a known region proximate to said mutation to form a target/primer duplex;

(b) exposing said duplex to one or more labeled nucleotides in the presence of a polymerase;

(c) incorporating one or more labeled nucleotide complementary to said target into said primer downstream of the duplex;

(d) identifying the incorporated labeled nucleotide; and

(e) repeating steps (b)-(d), thereby to determine if the mutation is present in said target.

2 . The method of claim 1 , wherein said primer is upstream of said mutation.

3 . The method of claim 1 , wherein said target is bound to a support.

4 . The method of claim 3 , wherein said support is glass.

5 . The method of claim 4 , wherein said glass has an epoxide coating thereon.

6 . The method of claim 5 , wherein said target is attached directly via an amine linkage.

7 . The method of claim 5 , wherein said target is attached via a linker pair.

8 . The method of claim 7 , wherein said linker pair is selected from biotin/avidin, antigen/antibody, and receptor/ligand.

9 . The method of claim 1 , the method further comprising the step of:

(f) shearing the target prior to step (a).

10 . The method of claim 9 , the method further comprising the step of:

(g) digesting the target.

11 . The method of claim 1 , wherein a 5′ end of a hybridized primer is between about 1 base and about 20 bases from the site suspected to contain a mutation.

12 . The method of claim 1 , wherein each of a plurality of targets is bound to a support.

13 . The method of claim 1 , wherein said polymerase is selected from the group consisting of Klenow, Nine degrees north, Vent, Taq, Tgo, sequenase, or any combination thereof.

14 . The method of claim 1 , wherein said nucleotide further comprises a removable blocking group attached to the 3′ hydroxyl.

15 . The method of claim 1 , wherein said target is exposed to a plurality of different nucleotide species, each comprising a different detectable label.

16 . The method of claim 1 , wherein said labeled nucleotide comprises an optically-detectable label.

17 . The method of claim 16 , wherein said optically-detectable label is a fluorescent label.

18 . The method of claim 17 , wherein said identifying step comprises exposing the incorporated labeled nucleotide to light that excites said fluorescent label.

19 . The method of claim 1 , wherein said incorporated labeled nucleotide is individually optically resolvable.

20 . A method for detecting a mutation in a target nucleic acid, the method comprising the steps of:

(a) exposing a target nucleic acid template suspected to contain a mutation to a primer capable of hybridizing to a known region proximate to said mutation;

(b) extending said primer, in the presence of at least one nucleotide, through a site suspected to contain said mutation in the presence of a polymerase;

(c) detaching the primer from said target;

(d) hybridizing a complement to the detached primer to form a duplex, wherein said duplex is individually-optically detectable;

(e) exposing said complement to at least one labeled nucleotide;

(f) identifying the incorporated labeled nucleotide; and

(g) repeating steps (e)-(f), thereby to detect if the mutation is present in said target.

21 . The method of claim 20 , wherein said primer is upstream of said mutation.

22 . The method of claim 20 , wherein each of the at least one nucleotides are unlabeled.

23 . The method of claim 20 , wherein the target is bound to a support.

24 . The method of claim 23 , wherein said support is glass.

25 . The method of claim 24 , wherein said glass has an epoxide coating thereon.

26 . The method of claim 25 , wherein said target is attached directly via an amine linkage.

27 . The method of claim 25 , wherein said target is attached via a linker pair.

28 . The method of claim 27 , wherein said linker pair is selected from biotin/avidin, antigen/antibody, and receptor/ligand.

29 . The method of claim 20 , wherein each of a plurality of targets is bound to a support.

30 . The method of claim 20 , wherein a 5′ end of a hybridized primer is between about 1 base and about 20 bases from the site suspected to contain a mutation.

31 . The method of claim 20 , the method further comprising the step of:

(h) exposing said complement to a plurality of chain terminating nucleotides.

32 . The method of claim 20 , wherein said polymerase is selected from the group consisting of Klenow, Nine degrees north, Vent, Taq, Tgo, sequenase, or any combination thereof.

33 . The method of claim 20 , wherein said nucleotide further comprises a removable blocking group attached to the 3′ hydroxyl.

34 . The method of claim 20 , wherein said target is exposed to a plurality of different nucleotide species, each comprising a different detectable label.

35 . The method of claim 20 , wherein said incorporated labeled nucleotide comprises an optically-detectable label.

36 . The method of claim 35 , wherein said optically-detectable label is a fluorescent label.

37 . The method of claim 36 , wherein said identifying step comprises exposing the incorporated labeled nucleotide to light that excites said fluorescent label.

38 . The method of claim 20 , wherein said incorporated labeled nucleotide is individually optically resolvable.

Assignments (6)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jun 28, 2013
From: HELICOS BIOSCIENCES CORPORATION
To: FLUIDIGM CORPORATION
Reel/Frame 030714/0546 →
LICENSE Recorded Jun 28, 2013
From: FLUIDIGM CORPORATION
To: PACIFIC BIOSCIENCES OF CALIFORNIA, INC.
Reel/Frame 030714/0598 →
LICENSE Recorded Jun 28, 2013
From: FLUIDIGM CORPORATION
To: SEQLL, LLC
Reel/Frame 030714/0633 →
LICENSE Recorded Jun 28, 2013
From: FLUIDIGM CORPORATION
To: COMPLETE GENOMICS, INC.
Reel/Frame 030714/0686 →
LICENSE Recorded Jun 28, 2013
From: FLUIDIGM CORPORATION
To: ILLUMINA, INC.
Reel/Frame 030714/0783 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Sep 26, 2007
From: EFCAVITCH, J. WILLIAM; CAUSEY, MARIE SUTHERLIN
To: HELICOS BIOSCIENCES CORPORATION
Reel/Frame 019878/0136 →